21![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived](https://www.pdfsearch.io/img/19718fd3b61ed8824e4c4570174a3e47.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
22![FOOD AND DRUG ADMINISTRATION FOOD AND DRUG ADMINISTRATION](https://www.pdfsearch.io/img/ac61d478339cc8185f375af00fe2d100.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
23![A Spike in Corporate Inversions •Caden ce Pharm aceuti cals •Actav is / Warne r •Chilco tt •Endo Health Solutio ns •Liber ty Global PLC A Spike in Corporate Inversions •Caden ce Pharm aceuti cals •Actav is / Warne r •Chilco tt •Endo Health Solutio ns •Liber ty Global PLC](https://www.pdfsearch.io/img/f4be30799a62980cb317be910f03b63a.jpg) | Add to Reading ListSource URL: democrats.waysandmeans.house.govLanguage: English - Date: 2014-07-07 11:56:46
|
---|
24![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993](https://www.pdfsearch.io/img/f13f497fb159c50bce78b2ff8779b0a2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
25![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993](https://www.pdfsearch.io/img/97c962093303fa89e509e99cc2017aef.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
26![NDA[removed] – FDA Approved Labeling Text dated January[removed]MEDICATION GUIDE AMPYRA® (am-PEER-ah) NDA[removed] – FDA Approved Labeling Text dated January[removed]MEDICATION GUIDE AMPYRA® (am-PEER-ah)](https://www.pdfsearch.io/img/cb1f882a6fdf04eea50f16456e834040.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
27![Richard F. Pops Chief Executive Officer Alkermes, Inc. Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in[removed]Under his leadership, Alkermes has grown from a privately Richard F. Pops Chief Executive Officer Alkermes, Inc. Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in[removed]Under his leadership, Alkermes has grown from a privately](https://www.pdfsearch.io/img/1ca18e4cdbf1a7b920d8cef7fb08818e.jpg) | Add to Reading ListSource URL: docs.house.govLanguage: English - Date: 2014-07-10 09:42:08
|
---|
28![](https://www.pdfsearch.io/img/9e734ef916d2d76d7a4e80787842d7c3.jpg) | Add to Reading ListSource URL: www.ampyra.comLanguage: English - Date: 2013-01-29 08:49:12
|
---|